

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total Revenue | 112.33 | 128.97 | 67.93 | 36.48 |
| Total Expenses | 81.06 | 90.81 | 54.34 | 27.81 |
| Profit Before Tax | 31.27 | 38.16 | 13.59 | 8.67 |
| Profit After Tax | 23.07 | 28.11 | 10.47 | 6.24 |
| Operating Profit After Depreciation | 33.37 | 38.77 | 14.13 | 8.87 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Fixed Assets | 95.44 | 80.84 | 20.14 | 14.50 |
| Total Non Current Assets | 114.37 | 100.73 | 21.46 | 15.53 |
| Total Current Assets | 77.58 | 70.20 | 33.82 | 25.81 |
| Total Assets | 191.94 | 170.94 | 55.28 | 41.34 |
| Total Shareholder's Fund | 145.16 | 122.10 | 42.20 | 33.82 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Net Cash From Operating Activities | 30.66 | 30.45 | 4.59 | -5.22 |
| Net Cash Used In Investing Activities | -35.48 | -33.09 | -2.91 | -0.08 |
| Net Cash Used In Financing Activities | -1.09 | 9.84 | -0.48 | -0.18 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 112.33 | 128.97 | 92.07 | 74.86 | 51.18 |
| Total Expenses | 81.03 | 90.80 | 71.84 | 56.85 | 38.23 |
| Profit Before Tax | 31.30 | 38.17 | 20.24 | 18.01 | 12.95 |
| Profit After Tax | 23.10 | 28.12 | 15.18 | 13.40 | 9.75 |
| Operating Profit After Depreciation | 33.37 | 38.77 | 20.42 | 18.15 | 13.02 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 95.44 | 80.84 | 58.27 | 27.19 | 18.85 |
| Total Non Current Assets | 114.45 | 100.82 | 75.75 | 32.11 | 22.61 |
| Total Current Assets | 77.53 | 70.13 | 62.22 | 44.91 | 37.99 |
| Total Assets | 191.98 | 170.94 | 137.97 | 77.02 | 60.60 |
| Total Shareholder's Fund | 145.19 | 122.11 | 87.20 | 61.57 | 50 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 30.66 | 30.45 | 17.10 | 13.42 | 3.31 |
| Net Cash Used In Investing Activities | -35.48 | -33.18 | -50.98 | -11.91 | -0.94 |
| Net Cash Used In Financing Activities | -1.06 | 9.85 | 38.66 | -1.09 | -0.66 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 33.20 | 21.11 | 30.32 | 24.67 | 24.43 |
| Total Expenses | 21.82 | 14.37 | 20.69 | 17.37 | 14.56 |
| Profit Before Tax | 8.72 | 3.99 | 6.72 | 4.60 | 8.77 |
| Profit After Tax | 6.27 | 3.09 | 4.96 | 3.45 | 6.59 |
| Operating Profit after Depreciation | 12.40 | 7.40 | 10.32 | 7.96 | 12.16 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 33.20 | 21.11 | 30.32 | 24.67 | 24.43 |
| Total Expenses | 21.82 | 14.37 | 20.69 | 17.37 | 14.56 |
| Profit Before Tax | 8.72 | 3.99 | 6.72 | 4.60 | 8.78 |
| Profit After Tax | 6.27 | 3.10 | 4.96 | 3.45 | 6.60 |
| Operating Profit after Depreciation | 12.40 | 7.40 | 10.32 | 7.96 | 12.16 |
₹0.5/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
| Fund Name | AUM |
|---|---|
| Bandhan BSE Healthcare Index Fund | 0.02% |
On 14 May 2026
12 May 2026, 11:50 am
Shree Ganesh Remedies Ltd has added 11.02% over last one month compared to 4.13% gain in BSE Healthcare index and 5.15% rise in the SENSEX
23 Apr 2026, 09:30 am
On 6 April 2026
14 Mar 2026, 03:05 pm
On 23 January 2026
17 Jan 2026, 10:02 am
On 7 November 2025
04 Nov 2025, 03:23 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.